chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: fell in shower; Sore Throat; fever of 101 degrees Fahrenheit; Nausea; Chills; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of FALL (fell in shower), OROPHARYNGEAL PAIN (Sore Throat), PYREXIA (fever of 101 degrees Fahrenheit), NAUSEA (Nausea) and CHILLS (Chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FALL (fell in shower), OROPHARYNGEAL PAIN (Sore Throat), PYREXIA (fever of 101 degrees Fahrenheit), NAUSEA (Nausea), CHILLS (Chills) and MYALGIA (Soreness). At the time of the report, FALL (fell in shower), OROPHARYNGEAL PAIN (Sore Throat), PYREXIA (fever of 101 degrees Fahrenheit), NAUSEA (Nausea), CHILLS (Chills) and MYALGIA (Soreness) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: high (High) 101 degrees Fahrenheit.         No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Skin swelling, Urticaria
Clinical narrative: Hives; Itchy; Puffy; Rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), PRURITUS (Itchy), SKIN SWELLING (Puffy) and RASH (Rash) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event .  Concomitant products included ATENOLOL, HYDROCHLOROTHIAZIDE, ALISKIREN FUMARATE (TEKTURNA), TERAZOSIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), THYROID (ARMOUR THYROID) and EZETIMIBE (ZETIA) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced URTICARIA (Hives), PRURITUS (Itchy), SKIN SWELLING (Puffy) and RASH (Rash). At the time of the report, URTICARIA (Hives), PRURITUS (Itchy), SKIN SWELLING (Puffy) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No treatment information provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Pain in extremity, Somnolence
Clinical narrative: feeling sleepy; not the hungry/ appetite came back; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (feeling sleepy), DECREASED APPETITE (not the hungry/ appetite came back) and PAIN IN EXTREMITY (arm was sore) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced SOMNOLENCE (feeling sleepy), DECREASED APPETITE (not the hungry/ appetite came back) and PAIN IN EXTREMITY (arm was sore). On 20-Feb-2021, PAIN IN EXTREMITY (arm was sore) had resolved. At the time of the report, SOMNOLENCE (feeling sleepy) and DECREASED APPETITE (not the hungry/ appetite came back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: Rash the size of a golf ball at the injection site; swelling the size of a golf ball at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash the size of a golf ball at the injection site) and VACCINATION SITE SWELLING (swelling the size of a golf ball at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concomitant products included METHOTREXATE, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), FAMOTIDINE, FOLIC ACID, HYDROCHLOROTHIAZIDE and GLUCOSAMINE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash the size of a golf ball at the injection site) and VACCINATION SITE SWELLING (swelling the size of a golf ball at the injection site). At the time of the report, VACCINATION SITE RASH (Rash the size of a golf ball at the injection site) and VACCINATION SITE SWELLING (swelling the size of a golf ball at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient felt rash an swelling in the size of golf ball at injection site.   No Treatment medication was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site nodule, Vaccination site swelling
Clinical narrative: swelling and a lump at the injection site; swelling and a lump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (swelling and a lump at the injection site) and VACCINATION SITE SWELLING (swelling and a lump at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE NODULE (swelling and a lump at the injection site) and VACCINATION SITE SWELLING (swelling and a lump at the injection site). At the time of the report, VACCINATION SITE NODULE (swelling and a lump at the injection site) and VACCINATION SITE SWELLING (swelling and a lump at the injection site) had resolved.            Concomitant medications were not provided Treatment information was not provided   This case was linked to MOD-2021-022879, MOD-2021-022868 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: sore arm; Chills; Fever; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHILLS (Chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (sore arm), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.  The patient was concerned about multisystem Inflammatory Syndrome (MIS) inflammatory death since she had Covid prior to the first vaccine.    This case was linked to MOD-2021-168297 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Upper right arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Upper right arm soreness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Upper right arm soreness). At the time of the report, VACCINATION SITE PAIN (Upper right arm soreness) outcome was unknown. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications reported by reporter. Treatment medication not reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Area at the site of injection is is worm; Arm pain since two weeks; Redness and swelling is 1 inch long and 1 inch. wide.; Redness and swelling is 1 inch long and 1 inch. wide; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Area at the site of injection is is worm), VACCINATION SITE PAIN (Arm pain since two weeks), VACCINATION SITE ERYTHEMA (Redness and swelling is 1 inch long and 1 inch. wide.) and VACCINATION SITE SWELLING (Redness and swelling is 1 inch long and 1 inch. wide) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Area at the site of injection is is worm), VACCINATION SITE PAIN (Arm pain since two weeks), VACCINATION SITE ERYTHEMA (Redness and swelling is 1 inch long and 1 inch. wide.) and VACCINATION SITE SWELLING (Redness and swelling is 1 inch long and 1 inch. wide). At the time of the report, VACCINATION SITE WARMTH (Area at the site of injection is is worm), VACCINATION SITE PAIN (Arm pain since two weeks), VACCINATION SITE ERYTHEMA (Redness and swelling is 1 inch long and 1 inch. wide.) and VACCINATION SITE SWELLING (Redness and swelling is 1 inch long and 1 inch. wide) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: events outcome updated.
Sex: F
Vaccine: COVID19
Symptoms: Lacrimation increased, Rhinorrhoea, Sneezing
Clinical narrative: bad runny nose and watery eyes; bad runny nose and watery eyes; sneezing; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (bad runny nose and watery eyes), RHINORRHOEA (bad runny nose and watery eyes) and SNEEZING (sneezing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LACRIMATION INCREASED (bad runny nose and watery eyes), RHINORRHOEA (bad runny nose and watery eyes) and SNEEZING (sneezing). At the time of the report, LACRIMATION INCREASED (bad runny nose and watery eyes), RHINORRHOEA (bad runny nose and watery eyes) and SNEEZING (sneezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: experienced lots of bleeding when he was injected; a little sore in the injection site; swelling at the injection site; lump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (experienced lots of bleeding when he was injected), VACCINATION SITE INDURATION (lump at the injection site), VACCINATION SITE PAIN (a little sore in the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (experienced lots of bleeding when he was injected) and VACCINATION SITE PAIN (a little sore in the injection site). On an unknown date, the patient experienced VACCINATION SITE INDURATION (lump at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). On 22-Feb-2021, VACCINATION SITE HAEMORRHAGE (experienced lots of bleeding when he was injected) outcome was unknown. At the time of the report, VACCINATION SITE INDURATION (lump at the injection site), VACCINATION SITE PAIN (a little sore in the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Exposure during pregnancy, Fatigue, Feeling abnormal, Headache
Clinical narrative: Felt horrible; Light headedness; body aches; elevated temperature no higher than 100.4; Fatigue; Body aches; Headaches; Vaccine exposure during pregnancy; after receiving the vaccine the patient started feeling unwell; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell), FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness) and PAIN (body aches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma, Infertility and In vitro fertilization. Concurrent medical conditions included Down's syndrome.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Jul-2021. On 26-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell). On 27-Jan-2021, the patient experienced FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness), PAIN (body aches), PYREXIA (elevated temperature no higher than 100.4), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headaches). On 26-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown. At the time of the report, VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell), FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness), PAIN (body aches), PYREXIA (elevated temperature no higher than 100.4), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: high (High) elevated temperature no higher than 100.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia, Vaccination complication
Clinical narrative: Felt horrible; Light headedness; body aches; elevated temperature no higher than 100.4; Fatigue; Body aches; Headaches; Vaccine exposure during pregnancy; after receiving the vaccine the patient started feeling unwell; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell), FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness) and PAIN (body aches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma, Infertility and In vitro fertilization. Concurrent medical conditions included Down's syndrome.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Jul-2021. On 26-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell). On 27-Jan-2021, the patient experienced FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness), PAIN (body aches), PYREXIA (elevated temperature no higher than 100.4), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headaches). On 26-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown. At the time of the report, VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell), FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness), PAIN (body aches), PYREXIA (elevated temperature no higher than 100.4), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: high (High) elevated temperature no higher than 100.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: Felt a little weak; Slight dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt a little weak) and DIZZINESS (Slight dizziness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced ASTHENIA (Felt a little weak) and DIZZINESS (Slight dizziness). At the time of the report, ASTHENIA (Felt a little weak) and DIZZINESS (Slight dizziness) was resolving.            No concomitant medications were provided No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: No new information regarding dose 1, and second dose updated.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Severe chills; Had a fever since 10PM; This spontaneous case was reported by a health care professional and describes the occurrence of CHILLS (Severe chills) and PYREXIA (Had a fever since 10PM) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced CHILLS (Severe chills) and PYREXIA (Had a fever since 10PM). At the time of the report, CHILLS (Severe chills) and PYREXIA (Had a fever since 10PM) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Left Shoulder hurting; left thigh burning; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Left Shoulder hurting) and PAIN IN EXTREMITY (left thigh burning) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETAMINOPHEN and DICLOFENAC POTASSIUM (VOLTAREN ACTI) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Left Shoulder hurting) and PAIN IN EXTREMITY (left thigh burning). At the time of the report, ARTHRALGIA (Left Shoulder hurting) and PAIN IN EXTREMITY (left thigh burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: redness on the same site of injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness on the same site of injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness on the same site of injection).   At the time of the report, VACCINATION SITE ERYTHEMA (redness on the same site of injection) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Vaccination site movement impairment
Clinical narrative: couldn't lift my arm; headache; very sore first day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't lift my arm), HEADACHE (headache) and MYALGIA (very sore first day) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't lift my arm), HEADACHE (headache) and MYALGIA (very sore first day). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Adverse event, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't lift my arm), HEADACHE (headache) and MYALGIA (very sore first day) had resolved.            Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Outcome of all events updated to recovered.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye pain, Fatigue, Myalgia, Nausea
Clinical narrative: RIGHT EYE HURTING; SHAKINESS; BLURRY EYE; NAUSEA WITHOUT VOMITING; LOW GRADE FEVER OF 101.4; MUSCLE ACHES; FATIGUE; CHILLS; This spontaneous case was reported by a health care professional and describes the occurrence of EYE PAIN (RIGHT EYE HURTING), TREMOR (SHAKINESS), VISION BLURRED (BLURRY EYE), NAUSEA (NAUSEA WITHOUT VOMITING) and PYREXIA (LOW GRADE FEVER OF 101.4) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced EYE PAIN (RIGHT EYE HURTING), TREMOR (SHAKINESS), VISION BLURRED (BLURRY EYE), NAUSEA (NAUSEA WITHOUT VOMITING), PYREXIA (LOW GRADE FEVER OF 101.4), MYALGIA (MUSCLE ACHES), FATIGUE (FATIGUE) and CHILLS (CHILLS). At the time of the report, EYE PAIN (RIGHT EYE HURTING), TREMOR (SHAKINESS), VISION BLURRED (BLURRY EYE), NAUSEA (NAUSEA WITHOUT VOMITING), PYREXIA (LOW GRADE FEVER OF 101.4), MYALGIA (MUSCLE ACHES), FATIGUE (FATIGUE) and CHILLS (CHILLS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   patient used unspecified eye drops as treatment medication
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vision blurred
Clinical narrative: RIGHT EYE HURTING; SHAKINESS; BLURRY EYE; NAUSEA WITHOUT VOMITING; LOW GRADE FEVER OF 101.4; MUSCLE ACHES; FATIGUE; CHILLS; This spontaneous case was reported by a health care professional and describes the occurrence of EYE PAIN (RIGHT EYE HURTING), TREMOR (SHAKINESS), VISION BLURRED (BLURRY EYE), NAUSEA (NAUSEA WITHOUT VOMITING) and PYREXIA (LOW GRADE FEVER OF 101.4) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced EYE PAIN (RIGHT EYE HURTING), TREMOR (SHAKINESS), VISION BLURRED (BLURRY EYE), NAUSEA (NAUSEA WITHOUT VOMITING), PYREXIA (LOW GRADE FEVER OF 101.4), MYALGIA (MUSCLE ACHES), FATIGUE (FATIGUE) and CHILLS (CHILLS). At the time of the report, EYE PAIN (RIGHT EYE HURTING), TREMOR (SHAKINESS), VISION BLURRED (BLURRY EYE), NAUSEA (NAUSEA WITHOUT VOMITING), PYREXIA (LOW GRADE FEVER OF 101.4), MYALGIA (MUSCLE ACHES), FATIGUE (FATIGUE) and CHILLS (CHILLS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   patient used unspecified eye drops as treatment medication
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: It feels warm; Huge rash in the injection site; Patient woke up and its like this big ol red circle on arm; It has itched for maybe 4 or 5 days; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (It feels warm), VACCINATION SITE PRURITUS (It has itched for maybe 4 or 5 days), VACCINATION SITE RASH (Huge rash in the injection site) and VACCINATION SITE ERYTHEMA (Patient woke up and its like this big ol red circle on arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (It has itched for maybe 4 or 5 days). On 04-Feb-2021, the patient experienced INJECTION SITE WARMTH (It feels warm), VACCINATION SITE RASH (Huge rash in the injection site) and VACCINATION SITE ERYTHEMA (Patient woke up and its like this big ol red circle on arm). At the time of the report, INJECTION SITE WARMTH (It feels warm), VACCINATION SITE PRURITUS (It has itched for maybe 4 or 5 days), VACCINATION SITE RASH (Huge rash in the injection site) and VACCINATION SITE ERYTHEMA (Patient woke up and its like this big ol red circle on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was not sure what to do other than take Benadryl.  No concomitant medications was provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Injection site inflammation
Clinical narrative: Flu like symptioms; slightly raised bright pink mark the size of a avocado at the injection upper right arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INFLAMMATION (slightly raised bright pink mark the size of a avocado at the injection upper right arm) and INFLUENZA LIKE ILLNESS (Flu like symptioms) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced INJECTION SITE INFLAMMATION (slightly raised bright pink mark the size of a avocado at the injection upper right arm). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptioms). At the time of the report, INJECTION SITE INFLAMMATION (slightly raised bright pink mark the size of a avocado at the injection upper right arm) and INFLUENZA LIKE ILLNESS (Flu like symptioms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Vision blurred
Clinical narrative: tingling in arms and face/ Nerve tingling; blurry vision; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (tingling in arms and face/ Nerve tingling) and VISION BLURRED (blurry vision) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis since 2016, Blood pressure high since 2000, Diabetes since 2019 and Spinal canal stenosis (Narrowing spine canal) since 2016. Concomitant products included LOSARTAN for Blood pressure high, INSULIN DETEMIR (LEVEMIR) and METFORMIN for Diabetes, DULOXETINE HYDROCHLORIDE (CYMBALTA) for Nerve pain, ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PARAESTHESIA (tingling in arms and face/ Nerve tingling) and VISION BLURRED (blurry vision). On 24-Feb-2021, PARAESTHESIA (tingling in arms and face/ Nerve tingling) and VISION BLURRED (blurry vision) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient presented to his doctor's office at 17:30 however his symptoms were receding at the time and he was told to monitor his symptoms, which resolved the same day.  No treatment was reported for the events.   This case was linked to MOD-2021-252561 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow up information was received and Rechallenge updated. On 09-Jul-2021: Updated reporter address. Updated patient demographics[Race], medical history.  Added Concomitant medicines.Updated Vaccination center details. Updated outcome of events from Unknown to Recovered.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Eye infection
Clinical narrative: Eye infection with pus in the lower part of the eye; This spontaneous case was reported by a consumer and describes the occurrence of   in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Diarrhoea, Fatigue, Myalgia
Clinical narrative: red arm/injection site red; abdominal cramps; diarrhea; fever; nausea; fatigue; muscle pain; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red arm/injection site red), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), PYREXIA (fever) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL, HYDROCHLOROTHIAZIDE, SERTRALINE, ACETYLSALICYLIC ACID (BABY ASPIRIN), METFORMIN HYDROCHLORIDE (METFORMIN ER), ATORVASTATIN, MULTIVITAMIN & MINERAL and MAGNESIUM for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red arm/injection site red), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), PYREXIA (fever), NAUSEA (nausea), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (joint pain). At the time of the report, VACCINATION SITE ERYTHEMA (red arm/injection site red), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), PYREXIA (fever), NAUSEA (nausea), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20-Apr-2021 included no new information. Consent to FU removed
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site erythema
Clinical narrative: red arm/injection site red; abdominal cramps; diarrhea; fever; nausea; fatigue; muscle pain; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red arm/injection site red), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), PYREXIA (fever) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL, HYDROCHLOROTHIAZIDE, SERTRALINE, ACETYLSALICYLIC ACID (BABY ASPIRIN), METFORMIN HYDROCHLORIDE (METFORMIN ER), ATORVASTATIN, MULTIVITAMIN & MINERAL and MAGNESIUM for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red arm/injection site red), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), PYREXIA (fever), NAUSEA (nausea), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (joint pain). At the time of the report, VACCINATION SITE ERYTHEMA (red arm/injection site red), ABDOMINAL PAIN (abdominal cramps), DIARRHOEA (diarrhea), PYREXIA (fever), NAUSEA (nausea), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20-Apr-2021 included no new information. Consent to FU removed
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: NNI
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Little pain at injection site; A spontaneous report was received from a Consumer concerning a 81-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced little pain at injection site/vaccination site pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 26 Jan 2021, the patient experienced little pain at injection site. Treatment details included paracetamol as prophylactic.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event, little pain at injection site was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pain in extremity, Peripheral swelling, Pyrexia, Vaccination site pruritus
Clinical narrative: hot at injection site; left arm swollen; itchy at injection site; felt feverish; injection site hot; Soreness in left arm; left arm swollen; red rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (hot at injection site) and PERIPHERAL SWELLING (left arm swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced INJECTION SITE WARMTH (hot at injection site) and PERIPHERAL SWELLING (left arm swollen). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (hot at injection site) and PERIPHERAL SWELLING (left arm swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site warmth
Clinical narrative: hot at injection site; left arm swollen; itchy at injection site; felt feverish; injection site hot; Soreness in left arm; left arm swollen; red rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (hot at injection site) and PERIPHERAL SWELLING (left arm swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced INJECTION SITE WARMTH (hot at injection site) and PERIPHERAL SWELLING (left arm swollen). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (hot at injection site) and PERIPHERAL SWELLING (left arm swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Headache, Hyperhidrosis, Hypoaesthesia
Clinical narrative: dizziness; headaches; sweaty palm on the left side; soreness in the shoulder; numbness in left side of face; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (soreness in the shoulder), HYPOAESTHESIA (numbness in left side of face), DIZZINESS (dizziness), HEADACHE (headaches) and HYPERHIDROSIS (sweaty palm on the left side) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ARTHRALGIA (soreness in the shoulder) and HYPOAESTHESIA (numbness in left side of face). On 16-Feb-2021, the patient experienced DIZZINESS (dizziness), HEADACHE (headaches) and HYPERHIDROSIS (sweaty palm on the left side). At the time of the report, ARTHRALGIA (soreness in the shoulder), HYPOAESTHESIA (numbness in left side of face), DIZZINESS (dizziness), HEADACHE (headaches) and HYPERHIDROSIS (sweaty palm on the left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-024113 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pruritus, Rash macular
Clinical narrative: Red spot; Itchy; weak and tired; A spontaneous report was received from a consumer concerning a 71-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itchy all over, feels weak and tired, Red spot on belly.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17-FEB-2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 300042698) via Intramuscular route for prophylaxis of COVID-19 infection.   On 21 FEB 2021, 5days after the vaccination the patient experienced the event(s) events itchy all over, feels weak and tired, Red spot on belly.  Treatment details for the events are not Included.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), itchy all over, feels weak and tired, Red spot on belly  was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Nausea, Pyrexia
Clinical narrative: headaches; resting heart rate is 106; nauseous; low grade fever; A spontaneous report was received from a consumer concerning a Drug Start Date-1963-1-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Headache, Heart rate increased ( resting heart rate is 106), Nausea (nauseous) and Pyrexia (lowgrade fever).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 043L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On unknown date, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 030M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced Low grade fever, Nauseous, Headaches and Resting heart rate is 106.  Treatment details included Excedrin PM.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Felt tired; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt tired), CHILLS (Chills) and PYREXIA (Fever) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced FATIGUE (Felt tired), CHILLS (Chills) and PYREXIA (Fever). On 22-Jan-2021, FATIGUE (Felt tired), CHILLS (Chills) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2020, SARS-CoV-2 test positive: positive (Positive) Patient had tested positive for COVID.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-024113 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: NNI- Reporter has declined for further follow up, as it was mild symptoms.